1. Increased Expression of Phosphatidylinositol 3-Kinase p110α and Gene Amplification of PIK3CA in Nasopharyngeal Carcinoma
   Wai Kien Yip et al, 2016, Pathol. Oncol. Res. CrossRef
2. Characterization of genetic rearrangements in esophageal squamous carcinoma cell lines by a combination of M-FISH and array-CGH: further confirmation of some split genomic regions in primary tumors
   Jia-Jie Hao et al, 2012, BMC Cancer CrossRef
3. Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.
   Ken Hatogai et al, 2017, BMC Cancer CrossRef
4. Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin’s lymphoma of mucosa-associated lymphoid tissue type
   Linzhu Zhai et al, 2011, Tumor Biol. CrossRef
5. Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia
   Wai Kien Yip et al, 2013, APMIS CrossRef
6. PIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients
   Wei-feng Wang et al, 2013, Acta Pharmacol Sin CrossRef
7. Genomic and molecular characterization of esophageal squamous cell carcinoma
   De-Chen Lin et al, 2014, Nat Genet CrossRef
8. Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)
   A.V. Tinker et al, 2013, Gynecologic Oncology CrossRef
9. Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients
   Zizhen Ming et al, 2014, Diagn Pathol CrossRef
10. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma
    Ali M. Al-Amri et al, 2016, CBM CrossRef
11. High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus
    Zhimin Zhang et al, 2014, BMC Cancer CrossRef
12. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma
    Shutao Zheng et al, 2016, Human Pathology CrossRef
13. Clinical significance of PIK3CA and survivin in primary adenosquamous lung carcinoma
    Shaomin Yu et al, 2014, Med Oncol CrossRef
14. Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma
    Jun Hou et al, 2014, Human Pathology CrossRef
15. Role of Phosphatidylinositol-3-Kinase Pathway in Head and Neck Squamous Cell Carcinoma
    Li Du et al, 2012, Journal of Oncology CrossRef
16. PIK3CA Gene Mutations and Overexpression: Implications for Prognostic Biomarker and Therapeutic Target in Chinese Esophageal Squamous Cell Carcinoma
    Lin Wang et al, 2014, PLoS ONE CrossRef
17. AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
    Moshe Elkabets et al, 2015, Cancer Cell CrossRef
18. A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma
    Li Shang et al, 2014, PLoS ONE CrossRef
19. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma
    Konstantia E. Tasioudi et al, 2015, APMIS CrossRef
20. Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation
    Xiaobin Chang et al, 2016 CrossRef
21. No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis
    Xiao-qing Ge et al, 2017, J. Huazhong Univ. Sci. Technol. [Med. Sci.] CrossRef
22. MiR-502 mediates esophageal cancer cell TE1 proliferation by promoting AKT phosphorylation
    Jing Xu et al, 2018, Biochemical and Biophysical Research Communications CrossRef
23. MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway
    Osamu Ishibashi et al, 2018, Biochemical and Biophysical Research Communications CrossRef
24. Oncogenic Mutations of PIK3CA in Human Cancers
    Yardena Samuels et al, 2010 CrossRef
25. PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome
    Fernanda Franco Munari et al, 2018, Infect Agents Cancer CrossRef
26. Development of New Molecular Markers for Cancer: A Highly Sensitive Assay for Detecting Mutations of Phosphatidylinositol 3-kinase and p53
    Nobutoshi Hagiwara et al, 2011, J Nippon Med Sch CrossRef
27. LINC01518 knockdown inhibits tumorigenicity by suppression of PIK3CA/Akt pathway in oesophageal squamous cell carcinoma
    Donghong Zhang et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
28. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
    Ali Alqahtani et al, 2019, Cancers CrossRef
29. Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway
    Anthony Adimonye et al, 2018, Oncotarget CrossRef
30. MicroRNA‑1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib
    Qianqian Yu et al, 2017, Oncol Lett CrossRef
31. Any Role of PIK3CA and PTEN Biomarkers in the Prognosis in Oral Squamous Cell Carcinoma?
    Anna Starzyńska et al, 2020, Life CrossRef
32. Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling
    Dorota Anusewicz et al, 2020, Sci Rep CrossRef
33. Reverse-Phase Protein Array Profiling of Oropharyngeal Cancer and Significance of PIK3CA Mutations in HPV-Associated Head and Neck Cancer
    Andrew Sewell et al, 2014, Clin Cancer Res CrossRef
34. PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Hironobu Shigaki et al, 2013, Clin. Cancer Res. CrossRef
35. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
    Le Yu et al, 2021, Seminars in Cancer Biology CrossRef
36. Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
    Xianhua Wu et al, 2012, J Transl Med CrossRef
37. Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy
    Xu Zhang et al, 2021, Acta Pharmaceutica Sinica B CrossRef
38. Integrated cohort of esophageal squamous cell cancer reveals genomic features underlying clinical characteristics
    Minghao Li et al, 2022, Nat Commun CrossRef
39. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway
    Hui Tong et al, 2022, Cellular Signalling CrossRef
40. The interplay between the PI3K/AKT pathway and circadian clock in physiologic and cancer‐related pathologic conditions
    Mohammad Rafi Khezri et al, 2024, Cell Proliferation CrossRef
41. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
    Shutao Zheng et al, 2024, Mol Biomed CrossRef
42. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma
    Yi-Xin Zhao et al, 2024, World J Gastroenterol CrossRef
43. Early Diagnostic Markers for Esophageal Squamous Cell Carcinoma: CNA Gene Identification and cfDNA Detection
    Jiamin Chen et al, 2024, Laboratory Investigation CrossRef
44. Current landscape of targeted therapy in esophageal squamous cell carcinoma
    Amane Jubashi et al, 2024, Current Problems in Cancer CrossRef